Infant Formula Recall Retirada del mercado de fórmula infantil

ALERT: ByHeart Recalls Whole Nutrition Infant Formula. Read more

AVISO IMPORTANTE: ByHeart retira del mercado su fórmula infantil Whole Nutrition. Aprender más

Transportation Update Actualización de transporte

Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.

Learn more here

For other questions, please call Member Services at the number on the back of your member ID card.

A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).

Obtenga más información AQUI

Si tiene otras preguntas, llame a Servicios para Miembros al número que aparece en la parte posterior de su tarjeta de identificación del miembro.

Search

Change in Preferred Drug List Status for Intranasal Rhinitis Agents

Date: September 30, 2025

Attention: All Providers

Effective date: September 29, 2025

Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers that effective September 29, 2025, the Texas Health and Human Services Commission (HHSC) removed non-preferred status from generic azelastine/fluticasone nasal products on the preferred drug list (PDL). This change is in response to a shortage brand Dymista products.

Impacted MedicationType of ChangeEffective Date
AZELASTINE/FLUTICASONE 137-50MCG SPRGeneric now preferredSeptember 29, 2025

How this impacts providers: The change will allow providers to prescribe the generic without requiring PDL prior authorization at this time and continue accessing necessary medication for their patients.

Next step for providers: Prescribers are encouraged to proactively obtain a prescription for the preferred alternatives to avoid disruption in patient’s therapy. Prescribers should share this communication with their staff.

If you have any questions, please email TCHP Pharmacy at: tchppharmacy@texaschildrens.org.

For access to all provider alerts: www.texaschildrenshealthplan.org/provideralerts.